Zobrazeno 1 - 7
of 7
pro vyhledávání: '"K. V. Naumova"'
The Effectiveness of MALDI ToF Mass Spectrometry in Identification of Francisella tularensis Strains
Autor:
A. K. Syngeeva, A. S. Ostyak, E. S. Kulikalova, A. V. Mazepa, K. V. Naumova, S. V. Balakhonov
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 3, Pp 145-150 (2022)
The aim of the study was to evaluate the effectiveness of MALDI‑ToF mass spectrometry in the identification of collection and newly isolated strains of tularemia pathogen using the database “Protein profiles of mass spectra of microorganisms belo
Externí odkaz:
https://doaj.org/article/47bed25540864db6b44dd8eed8e03de2
Publikováno v:
Российский кардиологический журнал, Vol 26, Iss 4S (2022)
The article is devoted to the modern understanding of endothelial dysfunction development, the role of hyperhomocysteinemia, and, as a consequence, hypertension in patients with multiple myeloma receiving multiagent chemotherapy. Considering that the
Externí odkaz:
https://doaj.org/article/0b6c990e5053459c8a6bd1fb4bfa68ec
Autor:
I. L. Davydkin, N. S. Popelnyuk, K. V. Naumova, E. V. Mordvinova, T. Yu. Stepanova, S. P. Krivova, A. A. Rogozina, T. P. Kuzmina
Publikováno v:
Сибирский научный медицинский журнал, Vol 39, Iss 1, Pp 58-65 (2019)
The target drugs use showed high efficiency and raised the patients’ life expectancy approaching it to average on population and became the new era in hematooncology. Given the currant tendency, the investigation of problems of patients’ quality
Externí odkaz:
https://doaj.org/article/b278a20fc39e41f49c1acf04ef58a453
Autor:
T. P. Kuzmina, I. L. Davydkin, O. V. Tereshina, O. E. Danilova, A. S. Shpigel, T. Sh. Betaneli, K. V. Naumova, N. S. Popelnyuk
Publikováno v:
Сибирский научный медицинский журнал, Vol 39, Iss 1, Pp 34-42 (2019)
The article is devoted to the modern concept of cardiotoxicity, induced chemotherapy in patients with hematological pathology and methods of its diagnosis. The study of cardiotoxicity is one of the current trends in oncology and oncohematology, as th
Externí odkaz:
https://doaj.org/article/fe30f7467e56410db19a856b34d09d90
Autor:
K. V. Naumova, I. L. Davydkin, E. G. Lomaia, T. Yu. Stepanova, T. P. Kuzmina, D. B. Zammoyeva
Publikováno v:
Российский кардиологический журнал, Vol 25, Iss 4S (2021)
CML), the accepting inhibitors tyrosine of kinases (TKI) I and the II generations (TKI1 and TKI2 respectively), and development of arterial hypertension.Material and methods. Examination of 137 patients with CML in the chronic phase (CP) is conducted
Externí odkaz:
https://doaj.org/article/7a98715a5136464fb8bd9a1692a72351
Autor:
A.M. Osadchuk, O E Danilova, I.L. Davydkin, LV Limareva, Intensive Care, Chapaevskaya str., Samara, Russian Federation, Biotechnology, Chapaevskaya str., Samara, Russian Federation, TP Kuz’mina, K V Naumova, TYu Stepanova, O.V. Tereshina, AS Shpigel, I.A. Zolotovskaya
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 11, Iss 4, Pp 378-387 (2018)
In the present review the cardiovascular complications in patients with chronic myeloid leukemia (CML) receiving tyrosine kinase inhibitors (TKI) are discussed. It covers current views on pathogenesis of TKI cardiovascular toxicity. The pathophysiolo
Publikováno v:
Russian Journal of Cardiology. 26:4573
The article is devoted to the modern understanding of endothelial dysfunction development, the role of hyperhomocysteinemia, and, as a consequence, hypertension in patients with multiple myeloma receiving multiagent chemotherapy. Considering that the